Literature DB >> 24012457

Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents.

Maria V Papadopoulou1, William D Bloomer, Howard S Rosenzweig, Marcel Kaiser, Eric Chatelain, Jean-Robert Ioset.   

Abstract

We have previously shown that 3-nitro-1H-1,2,4-triazole-based amines demonstrate significant trypanocidal activity, in particular against Trypanosoma cruzi, the causative parasite of Chagas disease. In the present work we further expanded our research by evaluating in vitro the trypanocidal activity of nitrotriazole-based piperazines and nitrotriazole-based 2-amino-1,3-benzothiazoles to establish additional SARs. All nitrotriazole-based derivatives were active or moderately active against T. cruzi; however two of them did not fulfill the selectivity criteria. Five derivatives were active or moderately active against Trypanosoma brucei rhodesiense while one derivative was moderately active against Leishmania donovani. Active compounds against T. cruzi demonstrated selectivity indexes (toxicity to host cells/toxicity to T. cruzi amastigotes) from 117 to 1725 and 12 of 13 compounds were up to 39-fold more potent than the reference compound benznidazole. Detailed SARs are discussed.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antitrypanosomal agents; Benzothiazoles; Bnz; Chagas disease; HAT; IC(50); NTR; Nfx; Nitrotriazoles; Piperazines; SARs; SI; Structure–activity relationships; T. brucei; T. brucei NTR; T. cruzi; TDR; TbNTR; Tropical diseases research (http://www.who.int/tdr/en/); Trypanosoma brucei; Trypanosoma cruzi; benznidazole (N-benzyl-2-(2-nitro-1H-imidazol-1-yl)acetamide); concentration for 50% growth inhibition; human African trypanosomiasis; nifurtimox (4-(5-nitrofurfurylindenamino)-3-methylthio-morpholine-1,1-dioxide); selectivity index; type I nitroreductase

Mesh:

Substances:

Year:  2013        PMID: 24012457      PMCID: PMC3873001          DOI: 10.1016/j.bmc.2013.08.022

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  33 in total

Review 1.  Kinetoplastids: related protozoan pathogens, different diseases.

Authors:  Ken Stuart; Reto Brun; Simon Croft; Alan Fairlamb; Ricardo E Gürtler; Jim McKerrow; Steve Reed; Rick Tarleton
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  Lead- and drug-like compounds: the rule-of-five revolution.

Authors:  Christopher A Lipinski
Journal:  Drug Discov Today Technol       Date:  2004-12

Review 3.  Chagas disease.

Authors:  Anis Rassi; Anis Rassi; José Antonio Marin-Neto
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

4.  Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness.

Authors:  Marcel Kaiser; Michael A Bray; Monica Cal; Bernadette Bourdin Trunz; Els Torreele; Reto Brun
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

5.  1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis.

Authors:  Bernadette Bourdin Trunz; Rafał Jędrysiak; David Tweats; Reto Brun; Marcel Kaiser; Jerzy Suwiński; Els Torreele
Journal:  Eur J Med Chem       Date:  2011-02-26       Impact factor: 6.514

6.  Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.

Authors:  Maria V Papadopoulou; Bernadette Bourdin Trunz; William D Bloomer; Caroline McKenzie; Shane R Wilkinson; Chaiya Prasittichai; Reto Brun; Marcel Kaiser; Els Torreele
Journal:  J Med Chem       Date:  2011-11-04       Impact factor: 7.446

7.  Chagas disease: a Latin American health problem becoming a world health problem.

Authors:  Gabriel A Schmunis; Zaida E Yadon
Journal:  Acta Trop       Date:  2009-11-20       Impact factor: 3.112

8.  Ergosterol biosynthesis and drug development for Chagas disease.

Authors:  Julio A Urbina
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

9.  Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness.

Authors:  Els Torreele; Bernadette Bourdin Trunz; David Tweats; Marcel Kaiser; Reto Brun; Guy Mazué; Michael A Bray; Bernard Pécoul
Journal:  PLoS Negl Trop Dis       Date:  2010-12-21

10.  Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: a provisional biopharmaceutical classification of the list of national essential medicines of Pakistan.

Authors:  R Shawahna; Nu Rahman
Journal:  Daru       Date:  2011       Impact factor: 3.117

View more
  14 in total

1.  How an Inhibitor Bound to Subunit Interface Alters Triosephosphate Isomerase Dynamics.

Authors:  Zeynep Kurkcuoglu; Doga Findik; Ebru Demet Akten; Pemra Doruker
Journal:  Biophys J       Date:  2015-07-16       Impact factor: 4.033

2.  Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.

Authors:  Maria V Papadopoulou; William D Bloomer; Galina I Lepesheva; Howard S Rosenzweig; Marcel Kaiser; Benjamín Aguilera-Venegas; Shane R Wilkinson; Eric Chatelain; Jean-Robert Ioset
Journal:  J Med Chem       Date:  2015-01-23       Impact factor: 7.446

3.  Nitrotriazole- and imidazole-based amides and sulfonamides as antitubercular agents.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Alexander Arena; Francisco Arrieta; Joseph C J Rebolledo; Diane K Smith
Journal:  Antimicrob Agents Chemother       Date:  2014-09-02       Impact factor: 5.191

4.  Nitrotriazole-Based Compounds as Antichagasic Agents in a Long-Treatment In Vivo Assay.

Authors:  Maria V Papadopoulou; William D Bloomer; Howard S Rosenzweig; Ana Lia Mazzeti; Karolina Ribeiro Gonçalves; Priscila Fagundes Mendes; Maria Terezinha Bahia
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

5.  Synthesis and antibacterial evaluation of new N- and S-glycosides analogues with dinitrophenyl-substituted heterocyclic bases.

Authors:  Fatima Belkhadem; Adil A Othman
Journal:  Mol Divers       Date:  2016-10-19       Impact factor: 2.943

6.  Phenylbenzothiazole derivatives: effects against a Trypanosoma cruzi infection and toxicological profiles.

Authors:  Sarai Martínez-Cerón; Nora Andrea Gutiérrez-Nágera; Elaheh Mirzaeicheshmeh; Roberto I Cuevas-Hernández; José G Trujillo-Ferrara
Journal:  Parasitol Res       Date:  2021-07-01       Impact factor: 2.289

7.  Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells.

Authors:  Robson Xavier Faria; Daniel Tadeu Gomes Gonzaga; Paulo Anastácio Furtado Pacheco; André Luis Almeida Souza; Vitor Francisco Ferreira; Fernando de Carvalho da Silva
Journal:  J Bioenerg Biomembr       Date:  2018-02-23       Impact factor: 2.945

8.  Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme.

Authors:  Alcione Silva de Carvalho; Kelly Salomão; Solange Lisboa de Castro; Taline Ramos Conde; Helena Pereira da Silva Zamith; Ernesto Raúl Caffarena; Belinda Suzette Hall; Shane Robert Wilkinson; Núbia Boechat
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-03-18       Impact factor: 2.743

9.  Utility of Diagnostic Imaging in the Diagnosis and Management of Schistosomiasis.

Authors:  David U Olveda; Remigio M Olveda; Alfred K Lam; Thao N P Chau; Yuesheng Li; Angelo Don Gisparil; Allen G P Ross
Journal:  Clin Microbiol       Date:  2014-04-15

Review 10.  Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects.

Authors:  Stephen Patterson; Susan Wyllie
Journal:  Trends Parasitol       Date:  2014-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.